Clinical Trials Browser

OTHER × Interventional × Breast × Clear all

NCT01570998 2026-03-18

Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery

Phase NA Active not recruiting

Breast Neoplasms

NCT01780064 2026-03-18

APAPI

Phase NA Terminated

Breast Neoplasms

NCT02422641 2026-03-18

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Phase 2 Recruiting

Breast Neoplasms, Meningeal Neoplasms

NCT02570100 2026-03-18

RepriM

Phase NA Terminated

Breast Neoplasms

NCT02861742 2026-03-18

KALICOU3

Phase NA Completed

Breast Neoplasms

NCT03795246 2026-03-18

KSF2

Phase NA Active not recruiting

Breast Neoplasms

NCT04038619 2026-03-18

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Phase 1 Recruiting

BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

NCT04789668 2026-03-18

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Phase 1/2 Terminated

8 enrolled 13 charts

BreastCNSDermatologicOther hematologic neoplasmThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Hematologic Neoplasms, Triple Negative Breast Neoplasms

NCT05286684 2026-03-18

Exo-LCR

Phase NA Completed

Breast Neoplasms, Meningeal Carcinomatosis

NCT05743686 2026-03-18

App for Adverse Events to Oral Chemotherapy - Pilot Study

Phase NA Completed

Breast Neoplasms

NCT05787834 2026-03-18

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer

Phase NA Recruiting

Breast Neoplasms

NCT06148038 2026-03-18

CBD for Breast Cancer Primary Tumors

Phase 1 Not yet recruiting

Breast Neoplasms

NCT06377852 2026-03-18

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Phase 3 Recruiting

Breast Neoplasms

NCT07015944 2026-03-18

Moving On ABC

Phase NA Recruiting

26,376 enrolled

Breast Neoplasms, Depression, Depressive Disorder, Major

NCT07446868 2026-03-18

SPSIP-ESPB

Phase NA Recruiting

Breast Neoplasms, Pain, Postoperative

NCT07478900 2026-03-18

TUMS

Phase NA Recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT00893061 2026-03-17

MNEMOSYNE

Phase 3 Completed

Breast Neoplasms

NCT02482376 2026-03-17

Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer

Phase 2 Active not recruiting

110 enrolled 18 charts

Breast Neoplasms

NCT02553967 2026-03-17

REMASCO

Phase NA Completed

Breast Neoplasms

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Phase 1 Recruiting

BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

NCT04653740 2026-03-17

OMERIC

Phase NA Active not recruiting

Breast Neoplasms

NCT05291507 2026-03-17

BreastMRgFUS

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT05656131 2026-03-17

Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer

Phase 2 Suspended

Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer

NCT06649331 2026-03-17

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06650748 2026-03-17

NeoMARS

Phase 2 Enrolling by invitation

Breast Neoplasms

NCT06807164 2026-03-17

SerCaBot

Phase 2 Recruiting

Agnosia, Breast Neoplasms

NCT07478315 2026-03-17

IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life

Phase NA Not yet recruiting

Breast Neoplasms, Hypersensitivity

NCT07478705 2026-03-17

EINSTEIN-TNBC

Phase NA Not yet recruiting

Recurrence, Triple Negative Breast Neoplasms

NCT07478718 2026-03-17

Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy

Phase NA Not yet recruiting

Breast Neoplasms

NCT00417495 2026-03-16

IGASSU

Phase 2 Completed

Adenocarcinoma, Breast Neoplasms

NCT01658462 2026-03-16

VAROCE

Phase 2 Completed

Breast Neoplasms

NCT03725436 2026-03-16

ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors

Phase 1 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT03742245 2026-03-16

Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT04039230 2026-03-16

Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT04253561 2026-03-16

IPATHER

Phase 1 Completed

Breast Neoplasms

NCT04531917 2026-03-16

BCS-PAIN

Phase NA Active not recruiting

Breast Neoplasms, Chronic Pain

NCT05309655 2026-03-16

CROWN

Phase NA Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05340413 2026-03-16

RADIOLA

Phase 2 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06075953 2026-03-16

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

Phase 2 Recruiting

Carcinoma, Intraductal, Noninfiltrating

NCT06450873 2026-03-16

Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery

Phase 2 Recruiting

Estrogen Receptor-Positive Breast Carcinoma

NCT06923527 2026-03-16

Circulating Tumor DNA

Phase 2 Recruiting

ER+ Breast Cancer

NCT07203729 2026-03-16

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

Phase 2 Recruiting

Breast Neoplasms

NCT07237256 2026-03-16

NoLEEta

Phase 3 Recruiting

Breast Neoplasms

NCT07474090 2026-03-16

STEPS-BC

Phase NA Not yet recruiting

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT07474246 2026-03-16

A Innovative Web-based Dance Movement Therapy

Phase NA Completed

Breast Neoplasms

NCT07474337 2026-03-16

The Effect of Mindfulness-Based Breathing Exercises on Symptom Control

Phase NA Recruiting

Breast Neoplasms

NCT00904410 2026-03-13

CHIMTEP

Phase 4 Completed

Adenocarcinoma, Breast Neoplasms

NCT01042379 2026-03-13

I-SPY

Phase 2 Recruiting

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT02515110 2026-03-13

Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

Phase NA Active not recruiting

Breast Carcinoma In Situ, Breast Neoplasms

NCT05373069 2026-03-13

PRIMIDIEP

Phase NA Completed

Breast Neoplasms